Solid tumour trials

We can deliver early and late phase, commercial and non-commercial clinical trials that are high to moderate risk complex drugs trials including advanced therapies of medicinal products and BiTEs. Our globally recognised clinicians are responsible for trials that are driving cutting-edge novel treatments that advance cancer treatment and care.

Case study: MORab-202

An Early Phase study looking at an antibody to a folate receptor that is expressed in a number of different cancers, linked to a drug that can kill cancer cells.

Case study: ATTEST

A new clinical trial using pioneering virus technology to infect cancer cells and start producing an anti-tumour drug from inside the tumour cells.